Article(id=1236331164001169688, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1236331158678597790, articleNumber=null, orderNo=null, doi=null, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=null, receivedDateStr=null, revisedDate=null, revisedDateStr=null, acceptedDate=1678636800000, acceptedDateStr=2023-03-13, onlineDate=1772693919420, onlineDateStr=2026-03-05, pubDate=1698595200000, pubDateStr=2023-10-30, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1772693919420, onlineIssueDateStr=2026-03-05, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1772693919420, creator=13701087609, updateTime=1772693919420, updator=13701087609, issue=Issue{id=1236331158678597790, tenantId=1146029695717560320, journalId=1235980733773295621, year='2023', volume='32', issue='20', pageStart='2009', pageEnd='2120', issueExtLink='null', onlineDate='null', pubDate='null', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1772693918151, creator=13701087609, updateTime=1772694963216, updator=13701087609, preIssue=null, nextIssue=null, ext={EN=IssueExt(id=1236335542061814375, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1236331158678597790, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1236335542061814376, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1236331158678597790, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null}, startPage=2022, endPage=2028, ext={EN=ArticleExt(id=1236331164215079196, articleId=1236331164001169688, tenantId=1146029695717560320, journalId=1235980733773295621, language=EN, title=Analysis of drugs marketed under the U.S. breakthrough therapy designation program and their innovation points, columnId=null, journalTitle=Chinese Journal of New Drugs, columnName=null, runingTitle=null, highlight=null, articleAbstract=
Objective:

To understand the innovation points of drugs marketed after the implementation of the U.S. breakthrough therapy designation (BTD) program, and provide a reference basis for the development of innovative drugs and the review of breakthrough therapy drugs in China.

Methods:

As of 2021, all BTD drugs approved by the U.S. FDA for marketing were collected, and the characteristics of these drugs in terms of innovative therapeutic modalities, treatment mechanisms, and technological breakthroughs were categorized and statistically analyzed.

Results:

The US FDA received 1 192 BTD drug applications and approved 242 for marketing. Among the marketed drugs, 42 (17%) were new drugs to fill clinical treatment gaps, 99 (41%) were drugs for expanded indications and new applicable populations, 27 (21%) were drug combinations for combination therapy, 16 (7%) were new drugs with more clinical treatment advantages, 31 (12.8%) were drugs with new mechanisms of action, and 12 (5%) were drugs prepared in new dosage forms or processes.

Conclusion:

The substantial improvement of the clinical efficacy of BTD drugs is reflected in the innovation of drugs and advancement of treatment.

, correspAuthors=null, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, authorCompany=null, fund=null, authors=null, authorsList=Ya-xing WANG, Shi-wei GONG), CN=ArticleExt(id=1236331164449960231, articleId=1236331164001169688, tenantId=1146029695717560320, journalId=1235980733773295621, language=CN, title=美国突破性治疗认定上市的药品及其创新点分析, columnId=1236331162679955859, journalTitle=中国新药杂志, columnName=新药述评与论坛, runingTitle=null, highlight=null, articleAbstract=
目的:

了解美国突破性治疗认定(BTD)程序实施后上市药品的创新点,为我国BTD药品的研发以及审评工作提供可借鉴的依据。

方法:

收集截至2021年美国FDA批准上市的BTD药品,对这些药品创新性的治疗模式、治疗机制和技术突破等方面的特点进行分类统计分析。

结果:

美国FDA获得1 192个BTD药品申请,审批上市242个。上市药品中有42个(17%)为填补临床治疗空白的新药,有99个(41%)为扩大适应证或新适用人群的药品,有27个(21%)为联合治疗的药品组合,有16个(7%)为更具临床治疗优势的新药,有31个(12.8%)为新作用机制药品,有12个(5%)为新的剂型或工艺制备的药品。

结论:

突破性治疗药品临床治疗功效的实质性提高,体现在药品的创新性和治疗的进步性两方面。

, correspAuthors=null, authorNote=null, correspAuthorsNote=
龚时薇,女,博士,教授,主要从事药事管理和药物政策研究。联系电话:(027)83692762,E-mail:
, copyrightStatement=null, copyrightOwner=《中国新药杂志》有限公司, extLink=null, articleAbsUrl=null, sourceXml=qS2hX+ZDJOZCEQ2IghX8dw==, magXml=9/NhnowtqNo0XEPiDUqOdA==, pdfUrl=null, pdf=EtyKi0CzFRZ1NS44IyruBQ==, pdfFileSize=2688315, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=d7uVzZQO+rR2HLPbxLut6A==, mapNumber=null, authorCompany=null, fund=null, authors=

王亚星,女,本科生在读,主要从事药品研发政策评估研究。E-mail:

, authorsList=王亚星, 龚时薇)}, authors=[Author(id=1236331164772921649, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331164001169688, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=yaxingwang@hust.edu.cn, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1236331164911333685, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331164001169688, authorId=1236331164772921649, language=EN, stringName=Ya-xing WANG, firstName=Ya-xing, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1236331165011996986, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331164001169688, authorId=1236331164772921649, language=CN, stringName=王亚星, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=华中科技大学同济医学院药学院,武汉 430030, bio={"content":"

王亚星,女,本科生在读,主要从事药品研发政策评估研究。E-mail:

"}, bioImg=null, bioContent=

王亚星,女,本科生在读,主要从事药品研发政策评估研究。E-mail:

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1236331164630315308, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331164001169688, xref=null, ext=[AuthorCompanyExt(id=1236331164634509613, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331164001169688, companyId=1236331164630315308, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China), AuthorCompanyExt(id=1236331164642898222, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331164001169688, companyId=1236331164630315308, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=华中科技大学同济医学院药学院,武汉 430030)])]), Author(id=1236331165104271677, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331164001169688, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=shwgong@hust.edu.cn, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1236331165196546370, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331164001169688, authorId=1236331165104271677, language=EN, stringName=Shi-wei GONG, firstName=Shi-wei, middleName=null, lastName=GONG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1236331165288821061, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331164001169688, authorId=1236331165104271677, language=CN, stringName=龚时薇, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=华中科技大学同济医学院药学院,武汉 430030, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1236331164630315308, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331164001169688, xref=null, ext=[AuthorCompanyExt(id=1236331164634509613, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331164001169688, companyId=1236331164630315308, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China), AuthorCompanyExt(id=1236331164642898222, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331164001169688, companyId=1236331164630315308, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=华中科技大学同济医学院药学院,武汉 430030)])])], keywords=[Keyword(id=1236331165393678664, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331164001169688, language=EN, orderNo=1, keyword=breakthrough therapy designation), Keyword(id=1236331165490147663, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331164001169688, language=EN, orderNo=2, keyword=innovative point of drug), Keyword(id=1236331165557256530, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331164001169688, language=EN, orderNo=3, keyword=new treatment model), Keyword(id=1236331165657919830, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331164001169688, language=EN, orderNo=4, keyword=new treatment mechanism), Keyword(id=1236331165783748959, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331164001169688, language=EN, orderNo=5, keyword=new technology), Keyword(id=1236331165876023655, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331164001169688, language=CN, orderNo=1, keyword=突破性治疗认定), Keyword(id=1236331165968298348, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331164001169688, language=CN, orderNo=2, keyword=药品创新点), Keyword(id=1236331166039601521, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331164001169688, language=CN, orderNo=3, keyword=新的治疗模式), Keyword(id=1236331166152847734, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331164001169688, language=CN, orderNo=4, keyword=新的治疗机制), Keyword(id=1236331166249316734, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331164001169688, language=CN, orderNo=5, keyword=新的技术)], refs=null, funds=[Fund(id=1236331166358368641, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331164001169688, awardId=71373089, language=CN, fundingSource=国家自然科学基金面上项目(71373089), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1236331164630315308, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331164001169688, xref=null, ext=[AuthorCompanyExt(id=1236331164634509613, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331164001169688, companyId=1236331164630315308, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China), AuthorCompanyExt(id=1236331164642898222, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331164001169688, companyId=1236331164630315308, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=华中科技大学同济医学院药学院,武汉 430030)])], figs=null, attaches=null, journal=Journal(id=1235980159023624194, delFlag=0, nameCn=中国新药杂志, nameEn=Chinese Journal of New Drugs, nameHistory1=null, nameHistory2=null, issn=1003-3734, eissn=null, cn=11-2850/R, coden=ZXZHA6, periodic=3, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=ohPEEN//Vz1tDT3ZBNTp4Q==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of New Drugs, journalRemark=null, publicationField=null, createdTime=1772610233314, updatedTime=1772610649152, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=C, firstLetterEn=C, subjectCode=Life Sciences, subjectName=null, subjectCodeEn=Life Sciences, subjectNameEn=null, picCn=ohPEEN//Vz1tDT3ZBNTp4Q==, picEn=f9WK9bvTM4guTmS/iGhOMg==, jcr=null, cjcr=null, exts=[JournalExt(id=1235981903275290962, language=CN, name=中国新药杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1772610649174, updatedTime=1772610649174, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://draft.newdrug.cn/journalx_zgxy/authorLogOn.action, submissionEditorUrl=http://draft.newdrug.cn/journalx_zgxy/editorLogOn.action, submissionReviewUrl=http://draft.newdrug.cn/journalx_zgxy/expertLogOn.action, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1235981903338205523, language=EN, name=Chinese Journal of New Drugs, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1772610649189, updatedTime=1772610649189, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://draft.newdrug.cn/journalx_zgxy/authorLogOn.action, submissionEditorUrl=http://draft.newdrug.cn/journalx_zgxy/editorLogOn.action, submissionReviewUrl=http://draft.newdrug.cn/journalx_zgxy/expertLogOn.action, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1235980733773295621, websiteList=[Website(id=1235982099191222761, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1235980733773295621, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgxyzz/CN, language=CN, createTime=1772610695884, createBy=18614031015, updateTime=1772610860397, updateBy=18614031015, name=中国新药杂志-中文, tplId=1146099689490845704, title=中国新药杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1235983918629966444, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=articleTextType, value=kx, createTime=1772611129672, updateTime=1772611129672, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918604800617, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=banner, value=null, createTime=1772611129666, updateTime=1772611129666, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918655132271, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=grayFlag, value=0, createTime=1772611129678, updateTime=1772611129678, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918596412008, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=logo, value=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/file/pic?fileId=W567vm71kFC7UhK9TSU6xw==, createTime=1772611129664, updateTime=1772611129664, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918667715185, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=minRunFlag, value=0, createTime=1772611129681, updateTime=1772611129681, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918617383531, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/file/pic, createTime=1772611129669, updateTime=1772611129669, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918659326576, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=silenceFlag, value=0, createTime=1772611129679, updateTime=1772611129679, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918613189226, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1772611129668, updateTime=1772611129668, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918634160749, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=themeColor, value=null, createTime=1772611129673, updateTime=1772611129673, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918646743662, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=themeStyle, value=null, createTime=1772611129676, updateTime=1772611129676, creator=18614031015, updator=18614031015)]), Website(id=1235982099270914542, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1235980733773295621, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgxyzz/EN, language=EN, createTime=1772610695903, createBy=18614031015, updateTime=1772610875891, updateBy=18614031015, name=中国新药杂志-英文, tplId=1146101810881728533, title=Chinese Journal of New Drugs, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1235983955829248630, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=articleTextType, value=kx, createTime=1772611138541, updateTime=1772611138541, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955804082803, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=banner, value=null, createTime=1772611138535, updateTime=1772611138535, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955854414457, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=grayFlag, value=0, createTime=1772611138547, updateTime=1772611138547, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955795694194, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=logo, value=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/file/pic?fileId=W567vm71kFC7UhK9TSU6xw==, createTime=1772611138533, updateTime=1772611138533, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955866997371, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=minRunFlag, value=0, createTime=1772611138550, updateTime=1772611138550, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955820860021, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/file/pic, createTime=1772611138539, updateTime=1772611138539, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955862803066, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=silenceFlag, value=0, createTime=1772611138549, updateTime=1772611138549, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955812471412, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1772611138537, updateTime=1772611138537, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955837637239, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=themeColor, value=null, createTime=1772611138543, updateTime=1772611138543, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955846025848, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=themeStyle, value=null, createTime=1772611138545, updateTime=1772611138545, creator=18614031015, updator=18614031015)])], journalTitle=中国新药杂志, weixinUrl=null, journalUrl=http://www.newdrug.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of New Drugs, journalPhotoCn=ohPEEN//Vz1tDT3ZBNTp4Q==, journalPhotoEn=f9WK9bvTM4guTmS/iGhOMg==, journalFirstLetter=C, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/Y2023/V32/I20/2022, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/Y2023/V32/I20/2022, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/PDF/Y2023/V32/I20/2022, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/PDF/Y2023/V32/I20/2022, aliStartDate=null, aliEndDate=null, collectionFlag=false, citedCount=null, citedUrl=null, reference=null)
收藏切换
美国突破性治疗认定上市的药品及其创新点分析
收藏切换
PDF下载
王亚星 , 龚时薇
中国新药杂志 | 新药述评与论坛 2023,32(20): 2022-2028
收起
收藏切换
中国新药杂志 | 新药述评与论坛 2023, 32(20): 2022-2028
美国突破性治疗认定上市的药品及其创新点分析
全屏
王亚星 , 龚时薇
作者信息
  • 华中科技大学同济医学院药学院,武汉 430030
  • 王亚星,女,本科生在读,主要从事药品研发政策评估研究。E-mail:

通讯作者:

龚时薇,女,博士,教授,主要从事药事管理和药物政策研究。联系电话:(027)83692762,E-mail:
Analysis of drugs marketed under the U.S. breakthrough therapy designation program and their innovation points
Ya-xing WANG , Shi-wei GONG
Affiliations
  • School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
出版时间: 2023-10-30
文章导航
收藏切换
目的:

了解美国突破性治疗认定(BTD)程序实施后上市药品的创新点,为我国BTD药品的研发以及审评工作提供可借鉴的依据。

方法:

收集截至2021年美国FDA批准上市的BTD药品,对这些药品创新性的治疗模式、治疗机制和技术突破等方面的特点进行分类统计分析。

结果:

美国FDA获得1 192个BTD药品申请,审批上市242个。上市药品中有42个(17%)为填补临床治疗空白的新药,有99个(41%)为扩大适应证或新适用人群的药品,有27个(21%)为联合治疗的药品组合,有16个(7%)为更具临床治疗优势的新药,有31个(12.8%)为新作用机制药品,有12个(5%)为新的剂型或工艺制备的药品。

结论:

突破性治疗药品临床治疗功效的实质性提高,体现在药品的创新性和治疗的进步性两方面。

突破性治疗认定  /  药品创新点  /  新的治疗模式  /  新的治疗机制  /  新的技术
Objective:

To understand the innovation points of drugs marketed after the implementation of the U.S. breakthrough therapy designation (BTD) program, and provide a reference basis for the development of innovative drugs and the review of breakthrough therapy drugs in China.

Methods:

As of 2021, all BTD drugs approved by the U.S. FDA for marketing were collected, and the characteristics of these drugs in terms of innovative therapeutic modalities, treatment mechanisms, and technological breakthroughs were categorized and statistically analyzed.

Results:

The US FDA received 1 192 BTD drug applications and approved 242 for marketing. Among the marketed drugs, 42 (17%) were new drugs to fill clinical treatment gaps, 99 (41%) were drugs for expanded indications and new applicable populations, 27 (21%) were drug combinations for combination therapy, 16 (7%) were new drugs with more clinical treatment advantages, 31 (12.8%) were drugs with new mechanisms of action, and 12 (5%) were drugs prepared in new dosage forms or processes.

Conclusion:

The substantial improvement of the clinical efficacy of BTD drugs is reflected in the innovation of drugs and advancement of treatment.

breakthrough therapy designation  /  innovative point of drug  /  new treatment model  /  new treatment mechanism  /  new technology
王亚星, 龚时薇. 美国突破性治疗认定上市的药品及其创新点分析. 中国新药杂志, 2023 , 32 (20) : 2022 -2028 .
Ya-xing WANG, Shi-wei GONG. Analysis of drugs marketed under the U.S. breakthrough therapy designation program and their innovation points[J]. Chinese Journal of New Drugs, 2023 , 32 (20) : 2022 -2028 .
  • 国家自然科学基金面上项目(71373089)
2023年第32卷第20期
PDF下载
29
11
引用本文
BibTeX
文章信息
  • 首发时间:2026-03-05
  • 出版时间:2023-10-30
补充材料
相关文章
文章信息
作者
出版历史
  • 录用日期:2023-03-13
基金
国家自然科学基金面上项目(71373089)
作者信息
    华中科技大学同济医学院药学院,武汉 430030

通讯作者:

龚时薇,女,博士,教授,主要从事药事管理和药物政策研究。联系电话:(027)83692762,E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgxyzz/CN/1236331164001169688
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏